Tech-Led Sell-Off Hits S&P 500 and Nasdaq

TITLE: Tech-Led Sell-Off Hits S&P 500 and Nasdaq

Big move in AI today. S&P 500 futures tick higher as traders look to recover — and it could change how you think about this space. Here is what happened and why it matters.

So here is the first thing — S&P 500 futures tick higher as traders look to recover from tech-led sell-off: Live. A rout in chipmaker names, including Micron, weighed the S&P 500 and Nasdaq Composite lower on Tuesday.

Meanwhile — London’s HERE at Outernet Announces Rebrand, Confirms Ticketmaster Partnership. The move comes as part of a broader strategy to strengthen the venue’s position within the capital's live music landscape.

And then there is this — Drug peptides defy shape rules, activating receptors without full spiral form. When many of us think about how drugs work in the body, we may first think about how a drug gets into the body, such as a pill versus an injection. In the Gellman Group at the UW–Madison Department of Chemistry, researchers are instead thinking about how a drug behaves after it reaches its target, which is critical for effective drug performance.

The bigger picture is simple: Tech-Led Sell-Off Hits S&P 500 and Nasdaq is no longer a one-off headline. It is turning into a broader AI shift people will keep talking about.

This matters because Tech-Led Sell-Off Hits S&P 500 and Nasdaq is shaping what people will expect from AI tools next. That makes it useful content for a broad audience, not just niche insiders.

That is the short version of what is happening with Tech-Led Sell-Off Hits S&P 500 and Nasdaq. If you found this useful, follow for more AI updates that actually make sense.

- Source 1: S&P 500 futures tick higher as traders look to recover from tech-led sell-off: Live updates

- Source 2: London’s HERE at Outernet Announces Rebrand, Confirms Ticketmaster Partnership

- Source 3: Drug peptides defy shape rules, activating receptors without full spiral form